Abstract 8879: Cardiac Radiotherapy Attenuates Angiotensin II-Induced Cardiac Fibrosisby Regulating Fibroblast Proliferation
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.8879 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Wanying Xia und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
As characterized by activation of fibroblasts, cardiac fibrosis is one of the major risk factors for heart failure and cardiovascular mortality. Angiotensin II (Ang II) is a key effector promoting fibroblast activation and regulating cardiac fibrosis. Because fibroblasts proliferate more actively than cardiomyocytes, they may be particularly sensitive to radiation. Recent studies show that 5 Gy cardiac radiotherapy (cRT) can mitigate adverse remodeling in murine heart failure models. However, the effects of 25 Gy cRT, the most commonly used dose in arrhythmia treatment, on Ang II-induced cardiac fibrosis and its underlying mechanisms remain unknown. Research Questions: Does 25 Gy cRT attenuate Ang II-induced cardiac fibrosis by modulating fibroblast proliferation? Which signaling pathways mediate the antifibrotic effects of cRT?
Methods
C57BL/6 mice were infused with Ang II (1600 ng/kg/min) or saline (Control) for 3 weeks. Ang II-treated mice were randomized to receive localized cardiac irradiation (25 Gy; Ang II+RT) or sham treatment (Ang II). Cardiac fibrosis was assessed 2 weeks post-cRT using Masson staining. Ventricular tissue underwent bulk RNA sequencing to identify cRT-responsive molecular pathways.
Results
Ventricular fibrosis was significantly reduced in Ang II+RT mice compared with Ang II alone (p < 0.01). Notably, fibrosis levels in Ang II+RT were comparable to saline controls (p > 0.05). RNA sequencing identified 292 differentially expressed genes (112 down-regulated, 180 up-regulated) between Ang II and Ang II+RT groups. Gene ontology analysis indicated suppression of positive regulation of fibroblast proliferation. Gene set enrichment analysis revealed down-regulation of pathways associated with fibroblast activation, including TNF-α/NF-κB and TGF-β signaling.
Conclusions
Twenty-five Gy cRT markedly attenuates Ang II-induced cardiac fibrosis in mice by reducing fibroblast proliferation. This antifibrotic effect is associated with modulation of TNF-α/NF-κB and TGF-β signaling pathways. These findings support cRT as a potential therapeutic strategy for adverse cardiac remodeling.
Zitieren
APA
Xia, W., Liu, Y., Yang, B., & Tang, M. (2026). Abstract 8879: Cardiac Radiotherapy Attenuates Angiotensin II-Induced Cardiac Fibrosisby Regulating Fibroblast Proliferation. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.8879
Vancouver
Xia W, Liu Y, Yang B, Tang M. Abstract 8879: Cardiac Radiotherapy Attenuates Angiotensin II-Induced Cardiac Fibrosisby Regulating Fibroblast Proliferation. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.8879
BibTeX
@article{Xia2026,
author = {Xia, Wanying and Liu, Yuandong and Yang, Bingyu and Tang, Min},
title = {Abstract 8879: Cardiac Radiotherapy Attenuates Angiotensin II-Induced Cardiac Fibrosisby Regulating Fibroblast Proliferation},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.8879}
}
EUVIMED